| Secondary |
| Hypertension |
53.1% |
| Diabetes Mellitus |
8.3% |
| Drug Use For Unknown Indication |
6.8% |
| Osteoporosis |
3.4% |
| Cerebral Infarction |
2.8% |
| Depression |
2.5% |
| Helicobacter Infection |
2.5% |
| Hypercholesterolaemia |
2.5% |
| Cardiac Failure Chronic |
2.2% |
| Gastritis |
2.2% |
| Hyperuricaemia |
2.2% |
| Anxiety Disorder |
1.9% |
| Hyperlipidaemia |
1.9% |
| Arthralgia |
1.5% |
| Cardiovascular Disorder |
1.2% |
| Iga Nephropathy |
1.2% |
| Pneumonia |
1.2% |
| Cardiac Failure |
0.9% |
| Cryptococcosis |
0.9% |
| Dyslipidaemia |
0.9% |
|
| Cerebral Infarction |
13.8% |
| Liver Disorder |
13.8% |
| Blood Creatinine Increased |
6.2% |
| Tubulointerstitial Nephritis |
6.2% |
| Interstitial Lung Disease |
4.6% |
| Maternal Exposure During Pregnancy |
4.6% |
| Pulmonary Alveolar Haemorrhage |
4.6% |
| Renal Impairment |
4.6% |
| Rheumatoid Factor Increased |
4.6% |
| Scrotal Swelling |
4.6% |
| Wheezing |
4.6% |
| Agranulocytosis |
3.1% |
| Colon Adenoma |
3.1% |
| Colon Cancer |
3.1% |
| Dizziness |
3.1% |
| Drug Eruption |
3.1% |
| Eosinophilia |
3.1% |
| Eosinophilic Pneumonia |
3.1% |
| Oligohydramnios |
3.1% |
| Platelet Count Decreased |
3.1% |
|
| Concomitant |
| Hypertension |
42.4% |
| Product Used For Unknown Indication |
8.4% |
| Diabetes Mellitus |
6.3% |
| Prophylaxis |
6.2% |
| Rheumatoid Arthritis |
5.2% |
| Hyperlipidaemia |
3.0% |
| Insomnia |
2.8% |
| Type 2 Diabetes Mellitus |
2.6% |
| Gastritis |
2.5% |
| Constipation |
2.5% |
| Osteoporosis |
2.3% |
| Nephrogenic Anaemia |
2.2% |
| Atrial Fibrillation |
2.0% |
| Angina Pectoris |
1.8% |
| Hyperuricaemia |
1.8% |
| Metastatic Renal Cell Carcinoma |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Renal Cell Carcinoma |
1.6% |
| Pain |
1.5% |
| Hepatitis C |
1.5% |
|
| Renal Impairment |
10.3% |
| Vomiting |
8.9% |
| Rhabdomyolysis |
7.3% |
| Interstitial Lung Disease |
7.0% |
| White Blood Cell Count Decreased |
6.1% |
| Pyrexia |
5.9% |
| Death |
4.5% |
| Hypoglycaemia |
4.5% |
| Sepsis |
4.5% |
| Renal Failure |
4.2% |
| Blood Uric Acid Increased |
3.9% |
| Hyperkalaemia |
3.9% |
| Hypertension |
3.9% |
| Loss Of Consciousness |
3.9% |
| Pneumonia |
3.9% |
| Renal Failure Chronic |
3.9% |
| Renal Failure Acute |
3.6% |
| Cerebral Infarction |
3.4% |
| Platelet Count Decreased |
3.4% |
| Bradycardia |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
94.4% |
| Onychomycosis |
5.6% |
|
| Drug Interaction |
50.0% |
| Condition Aggravated |
25.0% |
| Dementia |
25.0% |
|
